Medicared For All Logo

Sarfraz Aly in Sugar Land, Texas

Home Texas Sugar Land

Sarfraz Aly has Infectious Disease as his primary medical specialty. Their primary office is: 6903 Brisbane Ct in Sugar Land, Texas. There are 3 additional office locations for Sarfraz Aly that can be viewed towards the end of their profile.

They're a part of the: Capital Infectious Disease Associates medical group which has around 4 members. You can call their office at 832-886-4994 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Eastern Virginia Medical School and graduated in 2009 (around 15 years of experience). They are listed as doing telehealth appointments.


Sarfraz Aly Office Phone and Directions

Sarfraz Aly
Capital Infectious Disease Associates
6903 Brisbane Ct
Sugar Land, Texas 77479
832-886-4994


Patient Ratings
Please rate your experience with Sarfraz Aly below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 832-886-4994


Enter a starting address:


Healthcare Info for Sarfraz Aly

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Eastern Virginia Medical School
Graduation Year: 2009
The Primary Medical Specialty for Sarfraz Aly is listed as: Infectious Disease
Approximate Years of Experience: 15
PAC (PECOS ID)#: 3274688387
NPI #: 1972766327
NPI Created On: 07/07/2008
NPI Last Updated Listed as: 05/19/2023
Primary Taxonomy Code: 207R00000X
License Number:
N4903
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Molina Marketplace
  • Celtic Insurance Company
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Urdu, Spanish.


Services and Procedures include:

  1. Removal of skin and tissue first 20 sq cm or less
  2. Removal of tissue from wounds per session
  3. Removal of tissue from wounds per session
  4. New patient office or other outpatient visit, typically 45 minutes
  5. New patient office or other outpatient visit, typically 60 minutes
  6. Established patient office or other outpatient visit, typically 15 minutes
  7. Established patient office or other outpatient, visit typically 25 minutes
  8. Established patient office or other outpatient, visit typically 25 minutes
  9. Established patient office or other outpatient, visit typically 40 minutes
  10. Established patient office or other outpatient, visit typically 40 minutes
  11. Initial hospital inpatient care, typically 50 minutes per day
  12. Initial hospital inpatient care, typically 70 minutes per day
  13. Subsequent hospital inpatient care, typically 25 minutes per day
  14. Subsequent hospital inpatient care, typically 35 minutes per day
  15. Hospital discharge day management, 30 minutes or less
  16. Hospital discharge day management, more than 30 minutes
  17. Initial nursing facility visit, typically 45 minutes per day
  18. Subsequent nursing facility visit, typically 15 minutes per day
  19. Subsequent nursing facility visit, typically 25 minutes per day
  20. Prolonged inpatient or observation hospital service first hour

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793873899

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793873903

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793873907

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793873911

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793873915

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: VIROLOGY

Name of Drug #1: MAVYRET

Open Associated Drug #1: 0074-2625-28


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793873931

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793873919

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793873923

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793873927

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793873935

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Additional Office Locations

1. Capital Infectious Disease Associates
2011 Fm 102 Rd
Wharton, TX 77488
Group Members: 4

Phone: 832-886-4994

Enter a starting address:


2. Capital Advanced Wound Care Pllc
6903 Brisbane Ct
Sugar Land, TX 77479
Suite 100
Group Members: 3


Enter a starting address:


3. Capital Advanced Wound Care Pllc
2011 Fm 102 Rd
Wharton, TX 77488
Group Members: 3


Enter a starting address:


Infectious Disease Professionals in Sugar Land

16605 Sw Fwy 410
Sugar-land, TX
Tmh Physician Associates Pllc

16605 Southwest Fwy 400 Mob3
Sugar-land, TX
Tmh Physician Associates Pllc

16605 Southwest Fwy
Sugar-land, TX
Tmh Physician Associates Pllc

16659 Southwest Fwy
Sugar-land, TX
Infectious Disease Specialist Of Texas,p.a.

16605 Sw Fwy 410
Sugar-land, TX
Tmh Physician Associates Pllc

16605 Southwest Fwy 400 Mob3
Sugar-land, TX
Tmh Physician Associates Pllc

Providers in Capital Infectious Disease Associates

1.Irma Alarcon Najera

6903 Brisbane Ct
Sugar Land Tx 77479-6845
Capital Infectious Disease Associates
Infectious Disease

2.Sarfraz Aly

6903 Brisbane Ct
Sugar Land Tx 77479-6845
Capital Infectious Disease Associates
Infectious Disease

3.Sarfraz Aly

2011 Fm 102 Rd
Wharton Tx 77488-8833
Capital Infectious Disease Associates
Infectious Disease

4.Zerin Chowdhury

2011 Fm 102 Rd
Wharton Tx 77488-8833
Capital Infectious Disease Associates
Physician Assistant

5.Honorine Mufuwah

6903 Brisbane Ct
Sugar Land Tx 77479-6845
Capital Infectious Disease Associates
Nurse Practitioner

View all 4 members of Capital Infectious Disease Associates medical group